Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • General
  • Short Ideas
  • Short Sellers
  • Social Media
  • Tech
  • Top Stories
  • Trading Ideas

Trump Media’s DJT Stock Tops Short Squeeze Leaderboard: Is Another Price Surge Coming?

By Surbhi Jain
May 14, 11:14 AM
DJT, the stock of Trump Media & Technology Group Corp., is currently ranked number one on the Short Squeeze Leaderboard with a high Short Squeeze Score of 99.41.

DJT

Read More
1 minute read
  • Contracts
  • Equities
  • General
  • Markets
  • News
  • Tech

GXO Logistics Deploys Robotics Solution For Sporting Goods Retailer In France

By Nabaparna Bhattacharya
May 14, 11:13 AM
GXO Logistics implements robotics solution for a global sporting goods retailer in France, streamlining order processing and enhancing adaptability in logistics.

CSD

Read More
2 minute read
  • Dividends
  • Earnings
  • Equities
  • General
  • Guidance
  • Movers
  • News

Fast-Food Feast: Jack In The Box’s CEO Dishes Out Strategy Amid Q2 Ups And Downs

By Shivani Kumaresan
May 14, 11:07 AM
Jack In The Box shares are trading higher after the company reported better-than–expected second-quarter FY24 adjusted EPS. The company reported a second-quarter FY24 sales decline of 7.7% year-on-year to $365.35 million, missing the analyst consensus estimate of $368.64 million.

JACK

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Trading Ideas

Pliant Therapeutics’ Drug Trial Shows Promise In Reversing Lung Fibrosis In Patients

By Vandana Singh
May 14, 10:39 AM
Phase 2a trial results of Pliant Therapeutics' bexotegrast (PLN-74809) for idiopathic pulmonary fibrosis. Reduced lung collagen, improved FVC, and cough severity, signaling potential fibrosis reversal.

PLRX

Read More
2 minute read
  • General
  • Government
  • News
  • Regulations
  • Tech
  • Top Stories

Alphabet’s Autonomous Vehicle Waymo Faces Scrutiny Over Traffic Violations

By Shivani Kumaresan
May 14, 10:28 AM
U.S. auto safety regulators probe Waymo self-driving vehicles for potential traffic violations, following 17 collisions. NHTSA examines 444 vehicles after reports of erratic behavior near traffic control devices, prompting broader scrutiny into autonomous performance.

AMZN

Read More
2 minute read
  • Analyst Color
  • Economics
  • Equities
  • General
  • Government
  • Markets
  • News

Meme Stock Surge ‘Bothers’ Former SEC Chair As GameStop, AMC Shares Rise Nearly 80% On Tuesday: ‘A Lot Closer To Gambling…Certainly Not Investing’

By Pooja Rajkumari
May 14, 10:20 AM
The former SEC chair suggested that the recent stock surge is more akin to gambling than trading or investing.

AMC

Read More
1 minute read
  • Biotech
  • General
  • News

Affimed Announces Acceptance Of An Abstract On Preclinical Data Of Its Innate Cell Engager AFM28 At The EHA 2024 Congress

By Benzinga Newsdesk
May 14, 10:12 AM
Treatment with AFM28 innate cell engager (ICE®), designed to target CD123-positive cancer cells in patients with acute myeloid leukemia (AML), led to dose-dependent tumor growth control in a validated in vivo mouse

AFMD

Read More
1 minute read
  • Biotech
  • General
  • News

Editas Medicine To Present Clinical Data From The RUBY And EdiTHAL Trials Of Reni-cel At The EHA 2024 Congress In June

By Benzinga Newsdesk
May 14, 10:10 AM
Editas Medicine, Inc. (NASDAQ:EDIT), a clinical-stage gene editing company, today announced that two abstracts, including one oral presentation and one poster presentation, detailing clinical data from the RUBY and

EDIT

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

FDA Declines To Approve Expanded Use of Dynavax’s Hepatitis B Vaccine In Hemodialysis Patients

By Vandana Singh
May 14, 10:10 AM
Latest regulatory update from Dynavax on HEPLISAV-B vaccine regimen for adults on hemodialysis, with FDA's Complete Response Letter.

DVAX

Read More
1 minute read
  • Biotech
  • General
  • News

Nurix Therapeutics Upcoming Oral Presentation Of Data From Ongoing Clinical Trial Of NX-5948, A Selective BTK Degrader, At EHA2024 June 13 – 16, 2024, In Madrid, Spain

By Benzinga Newsdesk
May 14, 10:04 AM
Overall response rate of 70% observed in 10 evaluable heavily pretreated CLL patients Data showcase deepening clinical responses with longer time on therapy in CLL patients including patients with resistance

NRIX

Posts pagination

Previous 1 … 104 105 106 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service